Case studies

Canadian market access.
Strategy in practice.

Explore how MORSE approaches complex pharmaceutical market access questions, from the initial challenge to a practical strategy.

Explore our case studies
Illustration connecting evidence, public reimbursement, private coverage and patient support with access strategy.

Featured case study · PSP strategy

OncologyCanada

How do you balance early access with a transition to funded therapy?

A payer-informed Patient Support Program assessment for a novel targeted oncology therapy in Canada.

Read case study
Patient Support Program strategyCanada
Planning the transition to funded therapyConceptual diagram linking early access, reimbursement navigation and funded therapy. Illustrates the strategy focus, not measured patient results or a guaranteed funding sequence. Early accessPlan the bridge Reimbursementnavigation Funded therapyPlan the transition

A strategy focus, illustrated. Funding pathways vary by payer and jurisdiction.

The full collection

Explore our case studies

Browse every case, including our featured PSP strategy story.

Featured case study

PSP strategy · Oncology

Designing a Patient Support Program strategy

Assessing early access and the transition to funded therapy for a novel targeted oncology treatment in Canada.

What the work provided

MORSE mapped anticipated reimbursement pathways and timelines to identify compassionate-supply and co-pay requirements and associated financial risks before and after public funding was established.

Read case study

What does your next access challenge look like?

Connect with MORSE to discuss your Canadian market access priorities.

Discuss your market access challenge